Daito Pharmaceutical Co.,Ltd. (4577.T)
JPY 2079.0
(-3.71%)
JPY 2079.0
(-3.71%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 4.66 Billion JPY | 35.53% |
| 2022 | 3.44 Billion JPY | 53.32% |
| 2021 | 2.24 Billion JPY | 11.3% |
| 2020 | 2.01 Billion JPY | 27.56% |
| 2019 | 1.58 Billion JPY | -48.91% |
| 2018 | 3.09 Billion JPY | -23.08% |
| 2017 | 4.02 Billion JPY | 8.51% |
| 2016 | 3.71 Billion JPY | 0.54% |
| 2015 | 3.69 Billion JPY | 5.73% |
| 2014 | 3.49 Billion JPY | -21.96% |
| 2013 | 4.47 Billion JPY | -16.3% |
| 2012 | 5.34 Billion JPY | -3.62% |
| 2011 | 5.54 Billion JPY | -7.8% |
| 2010 | 6.01 Billion JPY | 1.17% |
| 2009 | 5.94 Billion JPY | -25.56% |
| 2008 | 7.98 Billion JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 8.84 Billion JPY | 89.42% |
| 2023 Q2 | 5.71 Billion JPY | 87.91% |
| 2023 FY | 4.66 Billion JPY | 35.53% |
| 2023 Q3 | 5.19 Billion JPY | -9.16% |
| 2023 Q4 | 4.66 Billion JPY | -10.11% |
| 2023 Q1 | 3.04 Billion JPY | -11.67% |
| 2022 Q1 | 4.42 Billion JPY | 96.84% |
| 2022 FY | 3.44 Billion JPY | 53.32% |
| 2022 Q4 | 3.44 Billion JPY | -6.99% |
| 2022 Q3 | 3.7 Billion JPY | -8.5% |
| 2022 Q2 | 4.04 Billion JPY | -8.48% |
| 2021 FY | 2.24 Billion JPY | 11.3% |
| 2021 Q1 | 1.74 Billion JPY | -13.61% |
| 2021 Q2 | 1.49 Billion JPY | -14.13% |
| 2021 Q3 | 2.48 Billion JPY | 66.12% |
| 2021 Q4 | 2.24 Billion JPY | -9.68% |
| 2020 Q2 | 1.02 Billion JPY | -20.51% |
| 2020 Q3 | 2.3 Billion JPY | 124.43% |
| 2020 Q4 | 2.01 Billion JPY | -12.36% |
| 2020 Q1 | 1.29 Billion JPY | -18.41% |
| 2020 FY | 2.01 Billion JPY | 27.56% |
| 2019 Q3 | 1.87 Billion JPY | -17.19% |
| 2019 FY | 1.58 Billion JPY | -48.91% |
| 2019 Q4 | 1.58 Billion JPY | -15.59% |
| 2019 Q1 | 2.67 Billion JPY | -13.53% |
| 2019 Q2 | 2.26 Billion JPY | -15.48% |
| 2018 FY | 3.09 Billion JPY | -23.08% |
| 2018 Q3 | 3.18 Billion JPY | -12.66% |
| 2018 Q2 | 3.64 Billion JPY | 1.4% |
| 2018 Q1 | 3.59 Billion JPY | -10.69% |
| 2018 Q4 | 3.09 Billion JPY | -2.75% |
| 2017 Q2 | 3.74 Billion JPY | 14.23% |
| 2017 FY | 4.02 Billion JPY | 8.51% |
| 2017 Q4 | 4.02 Billion JPY | 8.47% |
| 2017 Q3 | 3.71 Billion JPY | -0.96% |
| 2017 Q1 | 3.28 Billion JPY | -11.57% |
| 2016 Q4 | 3.71 Billion JPY | -4.52% |
| 2016 FY | 3.71 Billion JPY | 0.54% |
| 2016 Q1 | 3.18 Billion JPY | -13.85% |
| 2016 Q3 | 3.88 Billion JPY | 9.68% |
| 2016 Q2 | 3.54 Billion JPY | 11.44% |
| 2015 Q4 | 3.69 Billion JPY | -11.3% |
| 2015 Q3 | 4.16 Billion JPY | 62.21% |
| 2015 Q2 | 2.56 Billion JPY | -14.71% |
| 2015 FY | 3.69 Billion JPY | 5.73% |
| 2015 Q1 | 3 Billion JPY | -13.84% |
| 2014 Q1 | 3.51 Billion JPY | -21.38% |
| 2014 Q3 | 3.72 Billion JPY | 25.83% |
| 2014 Q4 | 3.49 Billion JPY | -6.35% |
| 2014 FY | 3.49 Billion JPY | -21.96% |
| 2014 Q2 | 2.96 Billion JPY | -15.77% |
| 2013 Q1 | 4.39 Billion JPY | -17.76% |
| 2013 Q3 | 3.97 Billion JPY | -10.82% |
| 2013 Q4 | 4.47 Billion JPY | 12.68% |
| 2013 FY | 4.47 Billion JPY | -16.3% |
| 2013 Q2 | 4.45 Billion JPY | 1.27% |
| 2012 Q1 | 5.18 Billion JPY | -6.56% |
| 2012 FY | 5.34 Billion JPY | -3.62% |
| 2012 Q3 | 5.06 Billion JPY | 1.57% |
| 2012 Q2 | 4.98 Billion JPY | -3.78% |
| 2012 Q4 | 5.34 Billion JPY | 5.54% |
| 2011 Q1 | 5.1 Billion JPY | -15.1% |
| 2011 Q2 | 4.82 Billion JPY | -5.52% |
| 2011 FY | 5.54 Billion JPY | -7.8% |
| 2011 Q3 | 5.22 Billion JPY | 8.29% |
| 2011 Q4 | 5.54 Billion JPY | 6.15% |
| 2010 Q2 | 4.65 Billion JPY | 6.72% |
| 2010 Q4 | 6.01 Billion JPY | 17.0% |
| 2010 Q3 | 5.14 Billion JPY | 10.5% |
| 2010 FY | 6.01 Billion JPY | 1.17% |
| 2010 Q1 | 4.36 Billion JPY | 0.0% |
| 2009 FY | 5.94 Billion JPY | -25.56% |
| 2008 FY | 7.98 Billion JPY | 0.0% |